MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from pre-funded
warrants, net of issuance...
$5,519,085
Proceeds from notes
issued during the year
$1,759,371
Proceeds from issuance of
common stock
$1,500,003
Net cash provided by
financing activities
$8,415,832
(39.73%↑ Y/Y)
Canceled cashflow
$362,627
Net change in cash
$4,940,171
(2282.17%↑ Y/Y)
Canceled cashflow
$3,475,661
Payments on factoring
payable
$179,007
(-0.77%↓ Y/Y)
Repayment of notes payable
$148,576
Payments on financing
lease liability
$25,000
Payment to shareholder
$10,000
Payments due on
acquisition purchase
$44
Accounts payable and
accrued liabilities
$4,235,940
(392.88%↑ Y/Y)
Depreciation and
amortization
$2,587,556
(95.51%↑ Y/Y)
Change in fair value of
financial instruments
-$1,450,271
(76.52%↑ Y/Y)
Stock-based compensation
$1,124,519
(25.43%↑ Y/Y)
Allowance for expected
credit losses
$1,029,317
(35.48%↑ Y/Y)
Deferred revenue
$836,671
(301.75%↑ Y/Y)
Loss on issuance of
financial instruments
-$668,020
(73.42%↑ Y/Y)
Encompass purchase
liability
-$386,082
Due from related
party
-$227,042
(10.75%↑ Y/Y)
Loss on
extinguishment of debt
-$221,202
(65.76%↑ Y/Y)
Prepaids and other
current assets
-$173,163
(-185.62%↓ Y/Y)
Loss on termination
of lease
-$140,709
Amortization of right-of-use
assets
$66,220
(19.40%↑ Y/Y)
Deferred income taxes
$51,814
(103.09%↑ Y/Y)
Net cash used in
operating activities
-$3,445,733
(40.48%↑ Y/Y)
Net cash used in
investing activities
-$29,928
(-14.47%↓ Y/Y)
Canceled cashflow
$13,198,526
Net loss
-$14,712,850
(74.50%↑ Y/Y)
Purchases of fixed assets
$29,928
(-45.85%↓ Y/Y)
Accounts receivable
$1,833,791
(67.59%↑ Y/Y)
Operating lease
liabilities
-$55,224
(40.54%↑ Y/Y)
Gain on
extinguishment of eloc
$42,394
Back
Back
Cash Flow
source: myfinsight.com
VSEE HEALTH, INC. (VSEEW)
VSEE HEALTH, INC. (VSEEW)